Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs.
Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
Episodes
125 total · newest first
Press play on any episode and the show keeps running from there.
Roche and Novartis part ways, Alphabet likes AI, Pfizer 89%, Series A, B, and the money that gets you thereFind out more athttps://thenichepod.comStory ReferencesRoche - NovartisAlphabetPfizerParthenonAntiosMission BioSection 32Music by Luk…
This week, we have a special bonus interview with Danielle Coe, founder of Black Women in Clinical Research. Danielle CoeBlack Women in Clinical ResearchBackground Danielle Coe started her career as a lab-based scientist, after learning fro…
Unique therapies including anti-opioid overdose, ocular implants, fish skin, UV light, digital therapeutics, and the impact of approvalsFind out more athttps://thenichepod.comStory Referenceshttps://tinyurl.com/Niche-074-1https://tinyurl.co…
The 26-year pipeline, CMDO divestment, oncology, and movement among COVID19 Therapies Find out more at https://thenichepod.com Story References https://tinyurl.com/Niche-073-1 https://tinyurl.com/Niche-073-2 https://tinyurl.com/Niche-073-3h…
Less than spiffy SPACs, big brains big money, Malaria buzz, vaccines, tests, series A, and Voyager gets a renewed lease on lifeFind out more athttps://thenichepod.comStory Referenceshttps://tinyurl.com/Niche-072-1https://tinyurl.com/Niche-0…
$11.5B acquisitions, we play “Who’s on First”, COVID19 therapy news, cancer Vaccines may be on the way, and CAR T for cancer is here to stayFind out more athttps://thenichepod.comStory Referenceshttps://tinyurl.com/Niche-071-1https://tinyur…
Double approval, double acquisition, $200M for tests, $200M for prostate robots, $450M for $1B worth of gummiesFind out more athttps://thenichepod.comStory Referenceshttps://tinyurl.com/Niche-070-1https://tinyurl.com/Niche-070-2https://tiny…
BeiGene’s oncology machine, China oncology pipelines, COVID costs, two new FDA approvals, $5B life science merger, and Hong Kong joins US SPAC party Find out more athttps://thenichepod.comStory Referenceshttps://tinyurl.com/Niche-069-1https…
$1.5B deal, $1.9B merger, protein degraders get backing, an old bird has new tricks, and another billion-dollar valuation for CRISPRFind out more athttps://thenichepod.comStory Referenceshttps://tinyurl.com/Niche-068-1 https://tinyurl.com/N…
This week, I go on vacation and give you a special bonus interview with Sam Searcy, founder and CEO of CliniStart and former NC State Senator Find out more athttps://thenichepod.comStory Referenceshttps://clinistart.com/https://www.samsearc…
The Cassava saga, Reify goes big… too big? Humacyte SPAC, vax news you already know, and a new growth hormone therapy – approved! Find out more athttps://thenichepod.comStory Referenceshttps://tinyurl.com/Niche-066-1https://tinyurl.com/Nich…
Alphabet buys, uncertain futures, new biotech funds, HIF-2a, PD-1, and a China Biotech emerges. Find out more athttps://thenichepod.comStory Referenceshttps://tinyurl.com/Niche-065-1 https://tinyurl.com/Niche-065-2https://tinyurl.com/Niche-…
This week, approvals for sleep and seizures across the pond, mRNA finds other SPACs, senior notes for CROs, FTC does a double take, IPOs, and boostersFind out more athttps://thenichepod.comStory Referenceshttps://tinyurl.com/Niche-064-1http…
Device acquisitions, rare disease approvals, COVID success stories, and clinical research ups and downs. Find out more athttps://thenichepod.comStory Referenceshttps://tinyurl.com/Niche-063-1https://tinyurl.com/Niche-063-2https://tinyurl.co…
This week, look closer – with drops, controlled gene therapy, acquisitions in antibodies, new antifungals, new biosimilars, and several IPOsFind out more athttps://thenichepod.comStory Referenceshttps://tinyurl.com/Niche-061-1https://tinyur…
In this special bonus episode, Dr. Noah Goodson sits down with biotech founders Dr. Shawn Carbonell and Dr. Brent Witgen to discuss their new founder-friendly biotech incubator Brazen Bio.Find out more athttps://thenichepod.comStory Referen…
Sequencing technology, decentralized Alzheimer’s trials, busts in gene therapy and microbiomes, and a $2.4B oncology collaboration Find out more athttps://thenichepod.comStory Referenceshttps://tinyurl.com/Niche-060-1https://tinyurl.com/Nic…
Muddy waters of data privacy and genetic databases, antibody-drug conjugate approvals, unabetted wild enthusiasm for CROs, and mobile MRIs go public. Story Referenceshttps://tinyurl.com/Niche-058-1https://tinyurl.com/Niche-058-2https://tiny…
Welcome to a special bonus episode as we kick off Season 2 the Niche Podcast. I sat down with Dr. Jayne Morgan, the head of the COVID19 task force at Piedmont Healthcare to talk about her career in clinical research. Sponsorshttps://www.the…
This is the last episode of Season 1 of the Niche Podcast. In line with that, I’ve got some announcements right at the top of the episode. Also, this week, congressional brakes, internal brakes, FDA brakes, and the first human CRISPR data. …
Kidney research, pet health, manufacturing is valuable, and a couple of biotech IPOs Sponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyurl.com/Niche-055-1https://tinyurl.com/Niche-055-2https://tinyurl.com/Niche-055-3https://…
We dive deep into Alzheimer’s, Regeneron execs might be overpaid, a merger in clinical research, and the FDA issues a Class 1 recallSponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyurl.com/Niche-054-1https://tinyurl.com/Nic…
Pending FDA approvals, expanded FDA approvals, new FDA approvals, and a lawsuit about FDA approvals.Sponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyurl.com/Niche-053-1https://tinyurl.com/Niche-053-2https://tinyurl.com/Nich…